Pharmaceuticals, Biotechnology and Life Sciences
— OncotoX-AML Effectively Ablated Myeloid Progenitor Cells that Give Rise to AML in Cancer Patients — SEATTLE–(BUSINESS WIRE)–Omeros Corporation (NASDAQ:…
– Pivotal Phase 3 Findings Support the Potential of a Novel Single-Tablet Combination of Bictegravir and Lenacapavir for HIV Treatment…
PLYMOUTH MEETING, Pa.–(BUSINESS WIRE)–Harmony Biosciences (Nasdaq: HRMY) today announced that the U.S. Food and Drug Administration (FDA) has approved its…
Noninvasive CyPath® Lung test has shown 92% sensitivity, 87% specificity and 88% accuracy for detecting lung cancer in small nodules…
First-in-human data for long-acting formulations of VH184, the first third-generation integrase inhibitor, and early data for capsid inhibitor VH499 to…
New research findings to be presented at Digestive Disease Week 2026 demonstrate that NIM-1324 outperforms current IBD medications and establish…
– Data Support the Study of RLYB116 as a Potential Best-In-Class Therapeutic for Multiple Complement Mediated Diseases – – Initiation…
—Industry veteran brings global regulatory expertise to support development of innovative optogenetic gene therapies— BERKELEY, Calif.–(BUSINESS WIRE)–Ray Therapeutics, a clinical-stage…
Appointment strengthens Artis platform strategy in nucleic acid medicines in connection with pending Syngoi acquisition SAN DIEGO–(BUSINESS WIRE)–Artis BioSolutions today…
Milestone achieved in Scribe and Lilly’s ongoing collaboration to develop in vivo CRISPR-based therapeutics for neurological and neuromuscular diseases Achievement…